ET-1 is indeed significantly higher in ME/CFS [29, 43, 44, 100] and long COVID [29, 31, 44, 100, 101] patients, along with some initial evidence of decreased NO expression and eNOS function in ME/CFS [41, 172, 176]. Here, EDN1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.